Octave Bioscience to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference

Bristol Myers Squibb to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

PRINCETON, N.J.--(BUSINESS WIRE)--Aug 29, 2025-

Octave Bioscience to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference

MENLO PARK, Calif.--(BUSINESS WIRE)--Aug 28, 2025-

Akero Therapeutics to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, today announced that management will present at…

10x Genomics to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

PLEASANTON, Calif., Aug. 27, 2025 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will participate in a fireside chat at the Morgan Stanley 23rd Annual…

Leucid Bio to Participate in Morgan Stanley 23rd Annual Global Healthcare Conference

LONDON, Aug. 28, 2025 /PRNewswire/ — Leucid Bio (“Leucid” or the “Company”), a privately-held biotechnology company pursuing the development of innovative Chimeric Antigen Receptor T-cell (CAR-T) therapies using the Company’s proprietary lateral CAR platform, today announced that it will attend the Morgan Stanley 23rd Annual Global Healthcare Conference in New York. Filippo Petti, Chief Executive Officer, will participate in a fireside chat at 1…